The assembly line producing the Ford Fiesta car in Cuautitlan Izcalli, Mexico. © Susana Gonzalez/Bloomberg via Getty Images
Mexico will soon be next car capital

Some 80% of the vehicles built south of the border are exported to other countries, mostly to the US.


Positive action on new drugs by FDA in 2011 bodes well for biopharmaceuticals in 2012, and Celgene can offer long-term growth.

By Gene Marcial Jan 9, 2012 9:37AM
SuperStockIs the Food and Drug Administration becoming more of an ally than an obstacle to young biotech companies? Some analysts are starting to believe so. The FDA last year approved 30 new drugs, the highest yearly total since 2004, which industry watchers say represents very positive news for biotech companies.


"We see the FDA's modestly raised fiscal 2012 budget supporting continued improvement in the approval of new drugs on first review cycle," says Steven Silver, a biotech analyst at Standard & Poor's. The FDA's approval of new drugs in 2011 jumped 63% after an increase of about 50% in 2010, indicating a much-improved dedication by the FDA in supporting biotech and pharmaceutical companies in their quest for badly needed new drugs, Silver argues.


A recently launched oil and gas trust offers protected payouts and attractive yield.

By TheStockAdvisors Jan 8, 2012 6:03PM
Image: Oil Well Pumpjack © Roger Milley/Vetta/Getty ImagesThis post is one in a series in which more than 50 newsletter advisers share their Top Picks for 2012.

By Elliott Gue, The Energy Strategist

Chesapeake Granite Wash Trust (CHKR), the newest addition to the universe of U.S. oil and gas trusts, went public on Nov. 11.  It is also among the most promising and fastest-growing trusts in my coverage universe. 

Diversified holdings in utilities, commodities and transportation sectors offer stable cash flow.

By TheStockAdvisors Jan 8, 2012 3:29PM
Image: Elevated view of freight cars with coal © Joseph Sohm-Visions of America/Photodisc/Getty ImagesThis post is one in a series in which over 50 newsletter advisors share their Top Picks for 2012.

By Gordon Pape,
The Canada Report

This will be a year of uncertainty. Since I am a conservative investor by nature, I am selecting a security with limited downside risk, stable assets and good cash flow.  
Tags: BIP

The year has started off well, but some sectors and strategies have the potential to pay off even better in coming weeks.

By Jan 7, 2012 1:40AM

By Tom Aspray,

The first week of the New Year has certainly been a good one for the stock market, as the S&P 500 finished the week up 1.3% and the Dow Industrials gained 1.1%. This was in contrast to the 3.4% gain in the Nasdaq-100.

There was little in the way of bad news from the eurozone (for a change), though yields on many of the euro bonds are still at dangerously high levels. Upcoming bond auctions in euro land will be watched closely.


Major oil producers saw output reduced because of the natural decline in production fields, asset sales and political issues.

By Trefis Jan 6, 2012 6:14PM
Image: Oil derricks (© Comstock/Corbis)Overall, 2011 was a strong year for the oil industry, with almost all companies showing revenue and profit growth as a result of high crude prices.

Brent prices remained above the $100 per barrel mark for most of the year, driven by an improved economic outlook in the first half of the year and supply concerns in the second half. The year also saw the announcement that ConocoPhillips (COP) would divest its downstream business and focus on upstream exploration and production and unconventional resources such as shale. 
Tags: bpCOPCVX

Gold miner has production volume, growth projects and seasonal factors in its favor.

By TheStockAdvisors Jan 6, 2012 6:10PM
Image: Gold (© Comstock Images/Jupiterimages)This post is one in a series in which over 50 newsletter advisors share their Top Picks for 2012.

By Curtis Hesler, The Professional Timing Service

There was a study done in the 1970’s that revealed that gold stocks tended to bottom in the fourth quarter and rally strongly into the end of the first quarter of the next year. Thus, looking for seasonal bargains in the gold sector makes sense, especially now. 
Tags: goldIAG

After enjoying months of cheaper fuel, Americans will soon experience more pain at the pump because of oil speculation and market manipulation.

By Anthony Mirhaydari Jan 6, 2012 5:19PM

Image: Gas station © Purestock/Purestock/Getty ImagesThere have been a lot of "funny" things happening in the market over the past two months. I chalk it up to a combination of end-of-year seasonality and a desire by the powers that be to keep the market together long enough to exit ahead of the fall. Something similar happened in 2008 before the most acute phase of the bear market got started.


Wall Street has apparently been using large-cap energy stocks Exxon Mobil (XOM) and Chevron (CVX) to hold the Dow Jones industrial Average aloft, ostensibly to keep retail investors placated so the heavy hitters can create the little upward flurries they need to exit their position. (This has to do with the fact the Dow is a price-weighted index that can be pushed around by the most expensive stocks.)


Pause a moment before you start building an investment strategy based on fourth-quarter reports.

By Jim J. Jubak Jan 6, 2012 4:27PM
Image: Arrows (© Image Source Black/Getty)Fourth-quarter earnings season kicks off Monday with Alcoa (AA) reporting after the close.

This earnings season promises to be wild and very hard to interpret.

Let me start with the narrow Alcoa story and then expand to look at the earnings season as a whole.
Tags: AAaig

The storage market is rapidly changing in the age of big data and cloud computing.

By Trefis Jan 6, 2012 3:57PM
EMC (EMC) is the global leader in the disk storage system market as well as the storage software market. However, the stock has fallen from highs of around $30 during the middle of 2011 to trade Friday at $22.

Even NetApp (NTAP), EMC's only major pureplay storage competitor, saw its stock tumble in the second half of 2011 largely due to concerns of lower government and enterprise spending as the macroeconomic condition deteriorated in the U.S. and Europe. 
Tags: EMCHPQibm

The biggest letdown is still under the hood.

By Motley Fool Pick of the Day Jan 6, 2012 3:12PM

Image: Los Angeles, Calif., traffic on Interstate 405 © VisionsofAmerica/Joe Sohm/Digital Vision/Getty ImagesBy Alex Planes


Electric cars started 2011 with a lot of hype and ended the year with a big face-plant. Combined sales for the plug-in electric movement's marquee names, General Motors' (GM) Chevy Volt and the Nissan Leaf, clocked in at fewer than 20,000 units. IDC Energy Insights predicted that half a million plug-ins would sell in 2011, which now seems downright silly.


Don't worry, IDC. You're far from the first to get burned by your love of the electric car.


Sabrient Systems has a strong track record, which is why its annual 'Baker's Dozen' list is getting attention.

By Kim Peterson Jan 6, 2012 2:18PM
Image: Arrow Up (© Nicholas Monu/iStock Exclusive/Getty Images)Sure, it's fine to pick stocks using philosophical models and what-would-Buffett-do theories, but you know how Wall Street does it? With computers and algorithms. Data mining. Statistical arbitrage.

Stuff you and I could never fathom.

So when one of the more respected quantitative investment shops releases its stock picks, people pay attention. And when that investment shop becomes known for beating the market year after year with those picks -- well, a lot of people pay attention. 

Technical methods identified the strongest and weakest sectors last year, and now they predict the best buying opportunities ahead.

By Jan 6, 2012 1:58PM

Image: Stock index © Image Source/Getty ImagesBy Tom Aspray,

The sector performance in 2011 further illustrates the year’s volatility. Many sectors had a few strong quarters, but the yearly performance numbers do not reflect the wide price swings.

Since the S&P 500 and its tracking exchange-traded fund (ETF) Spyder Trust (SPY) were essentially flat for the year, all the other Select Sector SPDR ETFs, except for Financials (XLF), Materials (XLB), and Industrials (XLI), performed better.


Treatments for myelofibrosis and arthritis could make biotech a takeover target for Big Pharma.

By TheStockAdvisors Jan 6, 2012 1:56PM
Image: Pills (© Digital Vision Ltd./SuperStock/SuperStock)This post is one in a series in which over 50 newsletter advisors share their Top Picks for 2012.

By John McCamant, The Medical technology Stock Letter

Incyte (INCY) is our top stock selection for 2012.  The Delaware company is a leader in developing small molecule drugs for cancer and inflammation.   
Tags: INCY

Housing plays are rising, including the venerable paint supplier and a faucet maker backed by a top hedge fund manager.

By Jan 6, 2012 1:28PM

Image: Woman Using a Spirit Level on a Sink in a Domestic Bathroom (© Alex Wilson/Digital Vision/Getty Images)By Igor Greenwald,

Stocks go up, stocks go down, and most of the time it means nothing at all. Much of the trading these days is done by computers scalping pennies over microseconds, and if the past year proved anything at all, it's that most of the apparent patterns generated by the hyperactive machines can't be trusted.

One day a stock is a breakout candidate, and then suddenly it's trashed. Just as the charts look like a lost cause, the market rockets higher.


Here's why shareholders are still unlikely to get any of the company's ever-mounting cash hoard.

By InvestorPlace Jan 6, 2012 12:48PM
By Kevin Kelleher, Technology and Markets Contributor

Apple investors should be some of the happiest shareholders on Wall Street. And for the most part, they are. But when it comes to the question of dividends, the gratitude vanishes.

Year after year, Apple (AAPL) investors ask about a dividend. Year after year, Apple declines to offer one, rewarding shareholders instead with handsome returns in its stock value. Apple returned investors more than 25% in 2011, a year when the rest of the market basically flat-lined.



Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

116 rated 1
275 rated 2
482 rated 3
656 rated 4
643 rated 5
650 rated 6
638 rated 7
485 rated 8
281 rated 9
127 rated 10

Top Picks


Trending NOW

What’s this?



Quotes delayed at least 15 min


Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.


There’s a problem getting this information right now. Please try again later.
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The S&P 500 continues hovering near its high, which is a bit surprising considering several noteworthy areas like biotechnology, chipmakers, transport stocks, and retailers underperform.

The biotech space is on its low with the iShares Nasdaq Biotechnology ETF (IBB 264.30, -2.55) down 1.0%. Elsewhere, the PHLX Semiconductor Index trades flat even as the technology sector outperforms with a gain of 0.5%.

Moving on, transport stocks have pressured the Dow ... More


There’s a problem getting this information right now. Please try again later.